Sarepta Therapeutics, Inc. (SRPT)
20.50
-1.52
(-6.90%)
USD |
NASDAQ |
Sep 10, 13:29
Sarepta Therapeutics Market Cap : 2.165B for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 2.326B |
| September 08, 2026 | 2.212B |
| September 04, 2026 | 2.377B |
| September 03, 2026 | 2.428B |
| September 02, 2026 | 2.452B |
| September 01, 2026 | 2.253B |
| August 31, 2026 | 2.221B |
| August 28, 2026 | 2.203B |
| August 27, 2026 | 2.280B |
| August 26, 2026 | 2.055B |
| August 25, 2026 | 1.998B |
| August 24, 2026 | 1.915B |
| August 21, 2026 | 1.985B |
| August 20, 2026 | 2.030B |
| August 19, 2026 | 2.084B |
| August 18, 2026 | 1.903B |
| August 17, 2026 | 1.920B |
| August 14, 2026 | 1.912B |
| August 13, 2026 | 1.946B |
| August 12, 2026 | 1.941B |
| August 11, 2026 | 1.924B |
| August 10, 2026 | 1.815B |
| August 07, 2026 | 1.772B |
| August 06, 2026 | 1.772B |
| August 05, 2026 | 1.683B |
| Date | Value |
|---|---|
| August 04, 2026 | 1.731B |
| August 03, 2026 | 1.677B |
| July 31, 2026 | 1.569B |
| July 30, 2026 | 1.643B |
| July 29, 2026 | 1.640B |
| July 28, 2026 | 1.629B |
| July 27, 2026 | 1.678B |
| July 24, 2026 | 1.655B |
| July 23, 2026 | 1.676B |
| July 22, 2026 | 1.670B |
| July 21, 2026 | 1.711B |
| July 20, 2026 | 1.777B |
| July 17, 2026 | 1.818B |
| July 16, 2026 | 1.819B |
| July 15, 2026 | 1.859B |
| July 14, 2026 | 1.896B |
| July 13, 2026 | 1.987B |
| July 10, 2026 | 2.001B |
| July 09, 2026 | 2.166B |
| July 08, 2026 | 2.134B |
| July 07, 2026 | 2.089B |
| July 06, 2026 | 2.025B |
| July 02, 2026 | 2.035B |
| July 01, 2026 | 1.921B |
| June 30, 2026 | 1.897B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 54.01B |
| Arrowhead Pharmaceuticals, Inc. | 11.74B |
| Beam Therapeutics, Inc. | 2.508B |
| Twist Bioscience Corp. | 8.022B |
| ImmunityBio, Inc. | 8.141B |
Market Cap Related Metrics
| PS Ratio | 1.122 |
| PEG Ratio | -0.0250 |
| Price to Book Value | 1.417 |
| Price to Free Cash Flow | 37.99 |
| Price | 20.50 |
| Earnings Yield | -14.13% |
| PEGY Ratio | -0.0250 |